BlackRock Amends Guardant Health Stake, Signals Continued Confidence
Ticker: GH · Form: SC 13G/A · Filed: Jan 25, 2024 · CIK: 1576280
| Field | Detail |
|---|---|
| Company | Guardant Health, Inc. (GH) |
| Form Type | SC 13G/A |
| Filed Date | Jan 25, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock still holds Guardant Health stock, showing continued institutional confidence.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on January 25, 2024, indicating its ownership of Guardant Health, Inc. (GH) common stock as of December 31, 2023. This filing, an amendment to a previous one, shows BlackRock's continued significant passive investment in Guardant Health. This matters to investors because BlackRock is a major institutional investor, and its sustained position suggests confidence in Guardant Health's long-term prospects, potentially influencing other investors.
Why It Matters
BlackRock's continued passive ownership in Guardant Health, as disclosed in this amendment, signals a stable institutional backing for the company, which can be a positive indicator for current and prospective shareholders.
Risk Assessment
Risk Level: low — This filing is a routine update from a major institutional investor and does not indicate any immediate negative or highly volatile changes.
Analyst Insight
Investors should view this as a routine update confirming BlackRock's ongoing, passive institutional support for Guardant Health, rather than a signal for immediate action. It reinforces the company's stability from a major investor's perspective.
Key Players & Entities
- BlackRock Inc. (company) — the reporting person and institutional investor
- Guardant Health, Inc. (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 25, 2024 (date) — the filing date of the SC 13G/A amendment
- 40131M109 (other) — the CUSIP number for Guardant Health's Common Stock
Forward-Looking Statements
- BlackRock will maintain a significant passive stake in Guardant Health. (BlackRock Inc.) — high confidence, target: next 12 months
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing under the Securities Exchange Act of 1934, as indicated by 'FORM TYPE: SC 13G/A' and 'Amendment No: 1'.
Who is the reporting person in this filing?
The reporting person is BlackRock, Inc., as stated under '(1)Names of reporting persons. BlackRock, Inc.'.
What is the subject company whose securities are being reported?
The subject company is Guardant Health, Inc., as identified under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Guardant Health, Inc.'.
What was the date of the event that required this filing?
The date of the event which required this filing was December 31, 2023, as specified under '(Date of Event Which Requires Filing of this Statement) December 31, 2023'.
Under which rule was this Schedule 13G/A filed?
This Schedule 13G/A was filed under Rule 13d-1(b), indicated by the 'X' next to '[X] Rule 13d-1(b)'.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 25, 2024 regarding Guardant Health, Inc. (GH).